Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004

被引:459
作者
Hemelaar, Joris
Gouws, Eleanor
Ghys, Peter D.
Osmanov, Saladin
机构
[1] WHO, UNAIDS, HIV Vaccine Initiat, CH-1211 Geneva 27, Switzerland
[2] Univ Oxford, Magdalene Coll, Oxford OX1 4AU, England
关键词
circulating recombinant form; distribution; genetic variability; HIV; molecular epidemiology; recombinants; subtypes;
D O I
10.1097/01.aids.0000247564.73009.bc
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To estimate the global and regional distribution of HIV-1 subtypes and recombinants in 2004. Design: A study was conducted in which molecular epidemiological data on HIV-1 subtype distribution in individual countries were combined with country-specific estimates of the number of people living with HIV. Methods: HIV-1 subtype data were collected for 23 874 HIV-1 samples from 70 countries, which together accounted for 89% of all people living with HIV worldwide in 2004. The proportions of HIV-1 infections due to various subtypes detected in each country were combined with the number of HIV infected people in the respective countries to generate regional and global HIV-1 subtype distribution estimates. Results: Subtype C accounted for 50% of all infections worldwide in 2004. Subtypes A, B, D and G accounted for 12%, 10%, 3% and 6%, respectively. The subtypes F, H, J and K together accounted for 0.94% of infections. The circulating recombinant forms CRF01_AE and CRF02_AG each were responsible for 5% of cases, and CRF03_AB for 0.1%. Other recombinants accounted for the remaining 8% of infections. All recombinant forms taken together were responsible for 18% of infections worldwide. Conclusion: Combining data on HIV-1 subtype distribution in individual countries with country-specific estimates of the number of people living with HIV provided a good method to generate estimates of the global and regional HIV-1 genetic diversity in 2004. The results could serve as an important resource for HIV scientists, public health officials and HIV vaccine developers.
引用
收藏
页码:W13 / W23
页数:11
相关论文
共 34 条
[1]   Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D [J].
Alaeus, A ;
Lidman, K ;
Björkman, A ;
Giesecke, J ;
Albert, J .
AIDS, 1999, 13 (08) :901-907
[2]  
[Anonymous], 2004, REP GLOB AIDS EP
[3]  
[Anonymous], 2006, REP GLOB AIDS EP
[4]  
[Anonymous], 2004, WORLD HLTH REPORT 20
[5]   Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: Relevance to HIV-1 vaccine trials in Uganda [J].
Cao, HY ;
Mani, I ;
Vincent, R ;
Mugerwa, R ;
Mugyenyi, P ;
Kanki, P ;
Ellner, J ;
Walker, BD .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (05) :1350-1356
[6]   Identification of a novel HIV-1 circulating AIDG intersubtype recombinant form (CRF1 9_cpx) in Cuba [J].
Casado, G ;
Thomson, MM ;
Sierra, M ;
Nájera, R .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (05) :532-537
[7]   Detection of high frequencies of HIV-1 cross-subtype reactive CD8 T lymphocytes in the peripheral blood of HIV-1-infected Kenyans [J].
Currier, JR ;
Dowling, WE ;
Wasunna, KM ;
Alam, U ;
Masons, CJ ;
Robb, ML ;
Carr, JK ;
McCutchan, FE ;
Birx, DL ;
Cox, JH .
AIDS, 2003, 17 (15) :2149-2157
[8]   Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how? [J].
Esparza, J ;
Bhamarapravati, N .
LANCET, 2000, 355 (9220) :2061-2066
[9]   Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy [J].
Frater, AJ ;
Dunn, DT ;
Beardall, AJ ;
Ariyoshi, K ;
Clarke, JR ;
McClure, MO ;
Weber, JN .
AIDS, 2002, 16 (08) :1139-1146
[10]   Prospects for an AIDS vaccine: three big questions, no easy answers [J].
Garber, DA ;
Silvestri, G ;
Feinberg, MB .
LANCET INFECTIOUS DISEASES, 2004, 4 (07) :397-413